Pfizer Inc. is recalling 5,390 vials of Propofol Injectable Emulsion (1 g/100 mL) due to the presence of visible particulate matter found in the solution. This recall affects medication packaged in 100 mL glass fliptop vials distributed by Hospira, Inc. No incidents or injuries have been reported to date. Healthcare providers and medical facilities should check their inventory for lot number EA7470 with an expiration date of June 1, 2023.
Injecting a drug containing particulate matter can cause serious health complications, such as blood clots, inflammation of the veins, or damage to vital organs like the lungs and heart.
Hospital-administered medication return
Distributed by Hospira, Inc.
Image Front Label: Propofol Injection Emulsion, 1g/100 mL (10mg/mL)
Image Side Label: Coding – L EA7470 EXP.: 01 JUN 2023
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.